RocketTickers

Xenon Pharmaceuticals Announces Positive Topline Results from Ph

Long
NASDAQ:XENE   Xenon Pharmaceuticals Inc
XENE: Xenon Pharmaceuticals Inc .
2021-10-04 07:00:00
Xenon Pharmaceuticals Announces Positive Topline Results from Phase 2b ‘X-TOLE’ Clinical Trial of XEN1101 for the Treatment of Focal Epilepsy
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.